Status:

COMPLETED

Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and Function

Lead Sponsor:

Texas A&M University

Collaborating Sponsors:

Arkansas Children's Hospital Research Institute

University of Arkansas

Conditions:

Cystic Fibrosis

Eligibility:

All Genders

10+ years

Phase:

NA

Brief Summary

Malnutrition is a significant problem in children and adults with Cystic fibrosis (CF). An impaired intestinal digestion and absorption capacity is one of the main factors responsible for the malnutri...

Eligibility Criteria

Inclusion

  • Adult subjects with CF
  • Diagnosis of CF based on universal diagnostic criteria
  • Pancreatic insufficiency based on clinical diagnosis
  • Abnormal lipid digestion requiring pancreatic enzyme replacement therapy
  • Age is 18 years and older.
  • Admitted to UAMS for treatment of exacerbations of CF (inpatients) or under routine medical control at the CF center of UAMS
  • Clinically stable CF at the time of enrollment
  • Healthy adults
  • Age is 18 years and older at the time of enrollment.
  • BMI between 18 and 35 kg/m2

Exclusion

  • Pediatric and adult CF groups
  • Unstable metabolic diseases including liver (cirrhosis) or renal disease
  • Chronic respiratory failure with cor pulmonale
  • Any other condition according to the principle investigator or study physician would interfere with proper conduct of study / safety of the patient
  • Failure to give assent / informed consent
  • Diagnosis of severe lung disease, defined as FEV1 \< 35% predicted
  • Healthy adults
  • Presence of acute or chronic unstable diseases such as liver, renal, heart or lung disease
  • Previous surgery less than 4 weeks prior to the experiment
  • Recent involuntary weight loss (\>10% in the past 3 months)
  • Any documented autoimmune disease
  • Any other condition according to the principle investigator or study physician would interfere with collecting study samples
  • Failure to give informed consent

Key Trial Info

Start Date :

November 15 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 7 2011

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT01494909

Start Date

November 15 2010

End Date

December 7 2011

Last Update

October 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States, 72205